Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity–standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study-Reference-Cited by-同舟云学术

Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity–standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study

Published:2009-03 Issue:3 Volume:102 Page:247-252
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Serrano Pilar,Justicia José-Luis,Sánchez Cesárea,Cimarra Mercedes,Fernández-Távora Laureano,Orovitg Agustín,Moreno Carmen,Guerra Francisco,Alvà Víctor

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference29 articles.

1. Immunotherapy: position paper of the EAACI;Malling;Allergy,1993

2. Determinants of patient compliance with allergen immunotherapy;Conh;J Allergy Clin Immunol,1993

3. Compliance with allergen immunotherapy;Lower;Ann Allergy,1993

4. Factors affecting compliance with allergen immunotherapy at a military medical center;More;Ann Allergy Asthma Immunol,2002

5. Safety considerations in assessing the role of immunotherapy in allergic disorders;Bousquet;Drug Safety,1994

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel dose-adjustment protocol for interrupted subcutaneous immunotherapy for allergic rhinitis;Immunotherapy;2023-10

2. Subcutaneous Allergen-Specific Immunotherapy Is Safe in Pediatric Patients with Allergic Rhinitis;International Archives of Allergy and Immunology;2021

3. Clinical assessment of tolerability, immunological and cutaneous reactivity effects of an abbreviated schedule with Olea europaeanative extract of subcutaneous immunotherapy;European Annals of Allergy and Clinical Immunology;2020-09

4. Comparison of adverse events between cluster and conventional immunotherapy for allergic rhinitis patients with or without asthma: A systematic review and meta-analysis;American Journal of Otolaryngology;2019-11

5. Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life;Immunotherapy;2019-06